Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity Maria J. PereiraJan W. Eriksson Leading Article Open access 30 January 2019 Pages: 219 - 230
The Impact of Comorbidities on the Pharmacological Management of Type 2 Diabetes Mellitus Shazia HussainTahseen A. Chowdhury Therapy in Practice 11 February 2019 Pages: 231 - 242
Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections Khalid EljaalyAisha AlharbiJason M. Pogue Review Article 06 February 2019 Pages: 243 - 269
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli George G. ZhanelAlyssa R. GoldenJames A. Karlowsky Review Article 02 February 2019 Pages: 271 - 289
Betrixaban for Extended Venous Thromboembolism Prophylaxis in High-Risk Hospitalized Patients: Putting the APEX Results into Practice Kayla M. MillerMichael J. Brenner Review Article 05 February 2019 Pages: 291 - 302
Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease Hannah A. Blair Adis Drug Evaluation 28 January 2019 Pages: 303 - 313
Eravacycline: A Review in Complicated Intra-Abdominal Infections Lesley J. Scott Adis Drug Evaluation Open access 20 February 2019 Pages: 315 - 324
Sarecycline: First Global Approval Emma D. Deeks AdisInsight Report Open access 18 January 2019 Pages: 325 - 329
Gilteritinib: First Global Approval Sohita Dhillon AdisInsight Report 05 February 2019 Pages: 331 - 339
Sintilimab: First Global Approval Sheridan M. Hoy AdisInsight Report 11 February 2019 Pages: 341 - 346